Study finds biomarker can predict how kidney cancer patients respond to immunotherapy

According to new research, a biomarker signature can predict how well kidney cancer patients will respond to immunotherapy before treatment even starts

Related Keywords

,Julie Stein Deutsch ,Janis Taube ,Bloomberg Kimmel Institute For Cancer Immunotherapy ,Division Of Dermatopathology ,Johns Hopkins University School Of Medicine ,Johns Hopkins Kimmel Cancer Center ,Tumor Microenvironment Laboratory ,Kimmel Institute ,Cell Reports ,Johns Hopkins University School ,Study ,Kinds ,Biomarker ,Han ,Redict ,Dow ,Kidney ,Dancer ,Patients ,Espond ,O ,Immunotherapy ,News ,Ews India ,